Clinical Trials
44 trialsA Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
St. James's Hospital, Ireland
PATH
VA Office of Research and Development
Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
CysPed
University Hospital, Toulouse
ARCH
University of Colorado, Denver
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
NiKang Therapeutics, Inc.
JAVELIN Renal 101
Pfizer
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
University of Alabama at Birmingham
MoveStrong
University of Waterloo
A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.
Guangzhou Red Pine Medical Instrument Co., Ltd.
PODRACING
University Hospital, Ghent
Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
University of Michigan
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Taiho Oncology, Inc.
MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.
University of Waterloo
STONE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Preparing Family Caregivers to Make Medical Decisions for Their Loved Ones
Milton S. Hershey Medical Center
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Aravive, Inc.
Parsabiv-MBD
Columbia University
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese
Meddoc
PACEinMM-QC
Université de Sherbrooke
Mesenchymal Stem Cells After Renal or Liver Transplantation
University of Liege
JAVELIN Renal 100
Pfizer
LISSE1
Centre Hospitalier Régional d'Orléans
SOROCOV
Butantan Institute
A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma
Celldex Therapeutics
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Celldex Therapeutics
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Celldex Therapeutics
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
Amgen
HCQIgAN
Peking Union Medical College Hospital
Renal Hypothermia During Partial Nephrectomy
Ottawa Hospital Research Institute
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
Stanford University
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate
Barretos Cancer Hospital
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Duke University
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device
Fenwal, Inc.
A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer
Astellas Pharma Inc
Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
National Institute of Allergy and Infectious Diseases (NIAID)
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)
Apeiron Biologics
Oxaliplatin in Cancer Patients With Impaired Kidney Function
National Institutes of Health Clinical Center (CC)
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
Bellus Health Inc. - a GSK company